Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

COLOPLAST A/S

(COLO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 923 DKK
Weaknesses
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
  • Based on current prices, the company has particularly high valuation levels.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 54.19 times its estimated earnings per share for the ongoing year.
  • The company is not the most generous with respect to shareholders' compensation.
  • Most analysts recommend that the stock should be sold or reduced.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart
Sector Medical Supplies
1st jan.Capitalisation (M$)Investor Rating
COLOPLAST A/S36.13%35 699
BECTON, DICKINSON AND COMPA..-9.21%73 045
TELEFLEX INCORPORATED-3.61%16 846
HARTALEGA HOLDINGS128.83%9 760
TOP GLOVE CORPORATION BHD.182.98%7 976
SHANDONG WEIGAO GROUP MEDIC..45.18%7 910
SHANDONG PHARMACEUTICAL GLA..66.17%3 829
KOSSAN RUBBER INDUSTRIES109.13%2 558
SUPERMAX CORPORATION453.96%2 302
NAKANISHI INC.-18.30%1 368
RIVERSTONE HOLDINGS LIMITED141.08%1 169
HOGY MEDICAL CO.,LTD.-1.40%991
ADVANCED MEDICAL SOLUTIONS ..-15.88%661
ANGIODYNAMICS, INC.-36.23%385
C.I. MEDICAL CO.,LTD.9.87%315
More Results
Financials
Sales 2020 18 973 M 2 827 M 2 827 M
Net income 2020 4 402 M 656 M 656 M
Net Debt 2020 783 M 117 M 117 M
P/E ratio 2020 54,2x
Yield 2020 1,60%
Capitalization 239 B 35 699 M 35 642 M
EV / Sales 2019
EV / Sales 2020 12,6x
Nbr of Employees 12 000
Free-Float 75,1%
Upcoming event on COLOPLAST A/S
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes